Foreign-Affiliated Pharmas Looking to Make “Sure Investments” to Avoid Risk of Discontinued Development: PhRMA Official

(from left) Mr Ono, Dr Fujimoto, and Dr Harada Heads of R&D at Japanese subsidiaries of drug makers affiliated with Pharmaceutical Research and Manufacturers of America (PhRMA) spoke in a recent interview with Jiho regarding the current state of drug...read more